ClinicalTrials.Veeva

Menu
T

Tyler Cardiovascular Consultants | Tyler, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Apixaban
REGN7508
REGN9933
Tezosentan
Olpasiran
cholesterol
MK-1242-035
MCC-135
Vericiguat
Aldosterone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 25 total trials

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardi...

Enrolling
Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo

This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which m...

Enrolling
Atrial Fibrillation (AF)
Drug: REGN9933
Drug: REGN7508

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called apixaban. T...

Enrolling
Atrial Fibrillation (AF)
Drug: Placebo
Drug: Apixaban

Trial sponsors

Bristol-Myers Squibb (BMS) logo
Medtronic logo
Amgen logo
C
Regeneron Pharmaceuticals logo
A
Bayer logo
Boston Scientific logo
C
Idorsia Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems